Melanocyte biology and its implications for the clinician

European Journal of Dermatology

Volumn 9, Issue 3, 1999, Pages 241-251

  Vancoillie, Garnet ^a   Lambert, Jo ^a   Naeyaert, Jean Marie ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Melanocyte; Melanogenesis; Melanoma; Melanosome biogenesis; Vitiligo

Indexed keywords

AGING; ARTICLE; CELL CONTACT; CYTOLOGY; EPIDERMIS CELL; HUMAN; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOSOME; NEURAL CREST; SKIN CARCINOGENESIS; SKIN CULTURE; SKIN PIGMENTATION; SUN EXPOSURE; VITILIGO;

ALBINISM, OCULOCUTANEOUS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CHEDIAK-HIGASHI SYNDROME; CULTURE TECHNIQUES; HUMANS; MELANINS; MELANOCYTES; MELANOMA; MELANOSOMES; SKIN DISEASES; VITILIGO;

EID: 0032949699     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. 1. Yaar M, Gilchrest B.A. Human melanocyte growth and differentiation: a decade of new data. J Invest Dermatol 1991; 97: 611-7.
2. 2. Abdek-Malek Z. Advances in long-term maintenance of normal human melanocytes in culture. In: The Pigmentary System, physiology and pathophysiology. Ed. Nordlund JJ, Biossy RE, Hearing VJ, King RA, Ortonne JP. Oxford University Press, New York, 1998: 159-63.
3. 3. Morita E, Lee DG, Sugiyama M, Yamamoto S. Expression of c-kit ligand in human keratinocytes. Arch Derm Res 1994; 286: 273-7.
4. 4. Grabbe J, Welker P, Dippel E, Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Derm Res 1994; 287: 78-84.
5. 5. Donatien P, Surlève-Bazeille JE, Thody AJ, Taïeb A. Growth and differentiation of normal human melanocytes in a TPA-free, cholera toxin-free, low-serum medium and influence of keratinocytes. Arch Dermatol Res 1993; 285: 385-2.
6. 6. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257: 1248-51.
7. 7. Wintzen M, Gilchrest BA. Proopiomelanocortin, its derived peptides and the skin. J Invest Dermatol 1996; 106: 3-10.
8. 8. Hedley SJ, Gawkrodger DJ, Weetman AP, Mac Neil S. α-MSH and melanogenesis in normal human adult melanocytes. Pigment Cell Res 1998; 11: 45-56.
9. 9. Sungbin I, Moro O, Peng F, Medrano EE, Cornelius J, Babcock G, Nordlund JJ, Abdel-Malek ZA. Activation of the cyclic AMP pathway by α-melanotropin mediated the response of human melanocytes to ultraviolet B radiation. Cancer Res 1998; 58: 47-54.
10. 10. Smit NPM, van der Meulen H, Koerten HK, Kolb RM, Mommaas AM, Lentjes EGWM, Pavel S. Melanogenesis in cultured melanocytes can be substantially influenced by l-tyrosine and l-cysteine. J Invest Dermatol 1997; 109: 796-800.
11. 11. Bessou S, Gauthier Y, Surlève-Bazeille JE, Pain C, Taïeb A. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease. Br J Dermatol 1997; 137: 890-7.
12. 12. Tobin DJ. Isolation and long-term culture of human hair-follicle melanocytes. J Invest Dermatol 1995; 104: 86-9.
13. 13. Eller MS, Ostrom K, Gilchrest BA. DNA damage enhances melanogenesis. Proc Natl Acad Sci USA 1996; 93: 1087-92.
14. 14. Roméro-Graillet C, Aberdam E, Clément M, Ortonne JP, Ballotti R. Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest 1997; 99: 635-42.
15. 15. Roméro-Graillet C, Aberdam E, Biagoli N, Massabni W, Ortonne JP, Ballotti R. Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem 1996; 271: 28052-6.
16. 16. Naeyaert JM, Eller M, Gordon P, Gilchrest B. Pigment content of cultured human melanocytes is independent of tyrosinase message level. Br J Dermatol 1991; 125: 297-303.
17. 17. Hearing VJ. Regulation of melanin formation. The pigmentary system of the skin, physiology and pathophysiology. Oxford Press, 1998: 423-38.
18. 18. Bertolotto C, Bille K, Ortonne JP, Ballotti R. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphtalmia gene product. J Cell Biol 1996; 134: 747-55.
19. 19. Englaro W, Rezzonico R, Durand-Clément M, Lallemand D, Ortonne JP, Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 1995: 24315-20.
20. 20. Buscà R, Bertolotto C, Ortonne JP, Ballotti R. Inhibition of the phosphatidylinositol 3-kinase/p70S6-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem 1996; 271: 31824-30.
21. 21. Jimbow K, Quevedo WC, Fitzpatrick TB, Szabo G. Biology of melanocytes. In: Dermatology in General Medicine. 3rd edition, edited by TB Fitzpatrick et al., New York, McGraw-Hill, 1993: 261-89.
22. 22. Chakraborty AK, Mishima Y, Inazu M, Hatta S, Ichihashi M. Melanogenic regulatory factors in coated vesicles from melanoma cells. J Invest Dermatol 1989; 93: 616-20.
23. 23. Jimbow K, Fitzpatrick TB. Characterization of a new melanosomal structural component-the vesiculoglobular body-by conventional transmission, high-voltage, and scanning electron microscopy. J Ultrastruct Res 1974; 48: 269-83.
24. 24. Orlow S. The biogenesis of melanosomes. In: The Pigmentary System, physiology and pathophysiology. Ed. Nordlund JJ, Biossy RE, Hearing VJ, King RA, Ortonne JP. Oxford University Press, New York, 1998: 97-106.
25. 25. Rosemblat S, Durham-Pierre D, Gardner JM, Nakatsu Y, Brilliant MH, Orlow SJ. Identification of a melanosomal membrane protein encoded by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proc Natl Acad Sci USA 1994; 91: 12071-5.
26. 26. Donatien PD, Orlow SJ. Interaction of melanosomal proteins with melanin. Eur J Biochem 1995; 232: 159-64.
27. 27. Rosemblat S, Sviderskaya EV, Easty DJ, Bennett DC, Orlow SJ. Melanosomal alterations in melanocytes cultured from p-null mice: effects of culture in the presence of tyrosine. 1998 (submitted).
28. 28. Gardner JM, Nakatsu Y, Gondo Y, Lee S, Lyon MF, King RA, Brilliant MH. The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science 1992; 257: 1121-4.
29. 29. Rinchik EM, Bultman SJ, Horsthemke B, Lee ST, Strunk KM, Spritz RA, Avidamo KM, Jong MTC, Nicholls RD. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 1993; 361: 72-6.
30. 30. Orlow SJ. Melanosomes are specialized members of the lysosomal lineage of organelles. J Invest Dermatol 1995; 105: 3-7.
31. 31. Windhorst DB, Zelickson AS, Good RA. Chediak-Higashi syndrome: hereditary gigantism of cytoplasmic organelles. Science 1966; 151: 81-3.
32. 32. Zelickson AS, Windhorst DB, White JG, Good RA. The Chediak-Higashi syndrome: formation of giant melanosomes and the basis of hypopigmentation. J Invest Dermatol 1967; 49: 575-81.
33. 33. Perou CM, Moore KJ, Nagle DL, Misumi DJ, Woolf EA, McGrail SH, Holmgren L, Brody TH, Dussault BJ Jr, Monroe CA, Duyk GM, Pryor RJ, Li L, Justice MJ, Kaplan J. Identification of the murine beige gene by YAC complementation and positional cloning. Nature Gen 1996; 13: 303-8.
34. 34. Barbosa MDFS, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, Brandt SJ, Chotai D, Hodgman C, Solari RCE, Lovett M, Kingsmore SF. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996; 382: 262-5.
35. 35. Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault BJ Jr, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nature Genet 1996; 14: 307-11.
36. 36. Frenk E, Lattion F. The melanin pigmentary disorder in a family with Hermansky-Pudlak syndrome. J Invest Dermatol 1982; 78: 141-3.
37. 37. Oh J, Bailin T, Fukai K, Feng GH, Ho L, Mao JI, Frenk E, Tamura N, Spritz RA. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nature Genet 1996; 14: 300-6.
38. 38. Pond L, Kuhn LA, Teyton L, Schutze MP, Tainer JA, Jackson MR, Peterson PA. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J Biol Chem 1995; 270: 19989-97.
39. 39. Gardner JM, Wildenberg SC, Keiper NM, Novak EK, Rusiniak ME, Swank RT, Puri N, Finger JN, Hagiwara N, Lehman AL, Gales TL, Bayer ME, King RA, Brilliant MH. The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci USA 1997; 94: 9238-43.
40. 40. Erickson RP. Commentary: pigment, platelets, and Hermansky-Pudlak in human and mouse. Proc Natl Acad Sci USA 1997; 94: 8924-5.
41. 41. Orlow SJ, Boissy RE, Moran DJ, Pifko-Hirst S. Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis. J Invest Dermatol 1993; 100: 55-64.
42. 42. Smit NPM, van Roermond CWT, Aerts HMFG, Heikoop JC, van den Berg M, Pavel S, Wanders RJA. Subcellular fractionation of cultured normal human melanocytes: new insights into the relationship of melanosomes with lysosomes and peroxisomes. Biochim Biophys Acta 1993; 1181: 1-6.
43. 43. Zhou BZ, Boissy RE, Pifko-Hirst S, Moran DJ, Orlow SJ. Lysosome-associated membrane protein-1 (LAMP-1) is the melanocyte vesicular membrane glycoprotein, Band II. J Invest Dermatol 1993; 100: 110-4.
44. 44. Vijayasaradhi S, Doskoch PM, Houghton AN. Biosynthesis and intracellular movement of the melanosomal membrane glycoprotein GP75, the human b (Brown) locus product. Exp Cell Res 1991; 196: 233-40.
45. 45. Winder AJ. Expression of a mouse tyrosinase cDNA in 3T3 Swiss mouse fibroblasts. Biochem Biophys Res Commun 1991; 178: 739-45.
46. 46. Diment S, Eidelman M, Rodriguez GM, Orlow SJ. Lysosomal hydrolases are present in melanosomes and are elevated in melanizing cells. J Biol Chem 1995; 270: 4213-5.
47. 47. Vijayasaradhi S, Xu Y, Bouchard B, Houghton AN. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein GP 75. J Cell Biol 1995; 130: 807-20.
48. p mutation). Exp Eye Res 1995; 61: 599-607.
49. 49. Lamoureux ML, Zhou BK, Rosemblat S, Orlow SJ. The pink-eyed dilution protein and the eumelanin/pheomelanin switch: in support of a unifying hypothesis. Pigment Cell Res 1995; 8: 263-70.
50. 50. Kobayashi T, Vieira WD, Potterf B, Sakai C, Imokawa G, Hearing VJ. Modulation of melanogenic protein expression during the switch from eu-to pheomelanogenesis. J Cell Sci 1995: 2301-09.
51. 51. Lacour JP, Gordon PR, Eller M, Bhawan J, Gilchrest BA. Cytoskeletal events underlying dendrite formation by cultured pigment cells. J Cell Physiol 1992; 151: 287-99.
52. 52. Baas PW, Deitch JS, Black MM, Banker GA. Polarity orientation of microtubules in hippocampal neurons: uniformity in the axon and nonuniformity in the dendrite. Proc Natl Acad Sci USA 1988; 85: 8335-9.
53. 53. Scott GA, Cassidy L. Racl mediates dendrite formation in response to melanocyte stimulating hormone and ultraviolet light in a murine melanoma model. J Invest Dermatol 1998; 111: 243-50.
54. 54. Nakazawa K, Salruc F, Danour O, Collombel C, Nakazawa H. Regulatory effects of heat on normal human melanocyte growth and melanogenesis: comparative study with UVB. J Invest Dermatol 1998: 972-7.
55. 55. Tomita Y, Iwamoto M, Masuda T, Tagami H. Stimulatory effect of prostaglandin E2 on the configuration of normal human melanocytes in vitro. J Invest Dermatol 1987; 89: 299-301.
56. 56. Kippenberger S, Bernd A, Bereiter-Hahn J, Ramirez-Bosca A, Kaufmann R. The mechanism of melanocyte dendrite formation: the impact of differentiating keratinocytes. Pigment Cell Res 1998; 11: 34-7.
57. 57. Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrest BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Science 1994; 107: 983-92.
58. 58. Hara M, Yaar M, Tang A, Eller M, Reenstra W, Gilchrest BA. Role of integrins in melanocyte attachment and dendricity. J Cell Science 1994; 107: 2739-48.
59. 59. Pastural E, Barrat FJ, Dufourq-Lagelouse R, Certain S, Sarrol O, Jabado N, Seger R, Griscelli C, Fischer A, Saint Basile G de. Griscelli maps to chromosome 15q21 and is associated with mutations in the myosin Va gene. Nature Genet 1997; 16: 289-92.
60. 60. Lambert J, Onderwater J, van der Haeghen Y, Vancoillie G, Koerten HK, Mommaas AM, Naeyaert JM. Myosin V colocalizes with melanosomes and subcortical actin bundles not associated with stress fibers in human epidermal melanocytes. J Invest Dermatol 1998; 111: 835-40.
61. 61. Rogers SL, Gelfand V. Myosin cooperates with microtubule motors during organelle transport in melanophores. Curr Biol 1998; 8: 161-4.
62. 62. Sharp DJ, Yu W, Ferhat L, Kuriyama R, Rueger DC, Baas PW. Identification of a microtubule-associated motor protein essential for dendritic differentiation. J Cell Biol 1997; 138 (4): 833-43.
63. 63. Dilman III JF, Dabney LP, Karki S, Paschal BM, Holzbaur EL, Pfister KK. Functional analysis of dynactin and cytoplasmic dynein in slow axonal transport. J Neuroscience 1996; 16 (21): 6742-52.
64. 64. Silvers WK. Dilute and Leaden, the p-locus, ruby-eye and ruby-eye-2. In Coat colours of mice: a model for mammalian gene action and interaction. Springer-Verlag, New York, 1979: 83-104.
65. 65. Yamamoto O, Bhawan J. Three modes of melanosome transfers in Caucasian facial skin: hypothesis based on ultrastructural study. Pigment Cell Res 1994; 7: 158-69.
66. 66. Nishikawa S, Kusakabe M, Yoshinaga K, Ogawa M, Hayazshi S, Kunisada T, Era T, Sakakura T, Nishikawa S. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J 1991; 10 (8): 2111-8.
67. 67. Spritz RA. Molecular basis of human pie-baldism. J Invest Dermatol 1994; 103: 137s-40.
68. 68. Hemesath TJ, Roydon Price E, Takemoto C, Badalian T, Fisher DE. MAP kinase links the transcription factor Microphtalmia to c-kit signaling in melanocytes. Nature 1998; 391: 298-301.
69. 69. Dekker SK. Modulation of expression and activation of cellular adhesion molecules on human melanoma cells. Thesis, Leiden, 1996.
70. 70. Naeyaert JM. Integrins in the melanocytic system. Eur J Dermatol 1993; 3: 379-81.
71. 71. Zambruno G, Marchisio PC, Melchiori A, Bondanza S, Cancedda R, De Luca M. Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J Cell Science 1993; 105: 179-90.
72. 72. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol 1993; 101: 605-8.
73. 73. Scott G, Ryan D, McCarthy JB. Molecular mechanisms of human melanocyte attachment to fibronectin. J Invest Dermatol 1992; 787-94.
74. 74. McClenic BK, Mitra RS, Riser BL, Nickoloff J, Dixit VM, Varani J. Production and utilization of extracellular matrix components by human melanocytes. Exp Cell Res 1989; 180: 314-25.
75. 75. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991; 97: 410-6.
76. 76. Ortonne JP, Mac Donald DM, Micoud A, Thivolet J. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultra-structural study. Br J Dermatol 1979; 101: 1-12.
77. 77. Ortonne JP, Schmitt D, Thivolet J. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol 1980; 74: 40-2.
78. 78. Yaar M, Grossman K, Eller M, Gilchrest BA. Evidence for nerve growth factor mediated paracrine effects in human epidermis. J Cell Biol 1991; 115: 821-8.
79. 79. De Luca M, Bondanza S, Di Marco E, Marchisio PC, D'Anna F, Franzi AT, Cancedda R. Keratinocyte-melanocyte interactions in in vitro reconstituted normal human epidermis. Keratinocyte Handbook, Cambridge University Press, Cambridge, UK, 1993.
80. 80. Horikawa T, Norris DA, Yohn JJ, Zekman T, Travers JB, Morelli JG. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 1995; 104: 256-9.
81. 81. Morelli JG, Kincannon J, Yohn JJ, Zekman T, Weston WL, Norris DA. Leukotriene C4 and TGFa are stimulators of human melanocyte migration in vitro. J Invest Dermatol 1992; 98: 290-5.
82. 82. Scott G, Ewing J, Ryan D, Abboud C. Stem cell factor regulates human melanocyte-matrix interactions. Pigment Cell Res 1994; 7: 44-51.
83. 83. Norris DA, Morelli JG, Fujita M. Melanocyte interactions in the skin. In: The pigmentary system, physiology and pathophysiology. Ed. Nordlund JJ, Biossy RE, Hearing VJ, King RA, Ortonne JP. Oxford University Press, New York, 1998: 123-33.
84. 84. Varani J, Mitra RS, McClenic BJ, Fligiel SE, Inman DR, Dixit VM, Nickoloff BJ. Modulation of fibronectin production in normal human melanocytes and malignant melanoma cells by interferon-γ and tumour necrosis factor-α. Am J Pathol 1989; 134: 827-36.
85. 85. Mould AP, Askari JA, Craig SE, Ganatt AN, Clements J, Humphries MJ. Integrin a4b1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced region of fibronectin. J Biol Chem 1994; 269: 27224-30.
86. 86. Hsu MY, Wheelock MJ, Johnson KR, Herlyn M. Shifts in cadherin profiles between normal human melanocytes and melanomas. J Invest Dermatol 1996; (suppl. 1): 188-94.
87. 87. Seline PC, Norris DA, Horikawa T, Fujita M, Middleton MH, Morelli JG. Expression of E-and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol 1996 ; 106: 1320-4.
88. 88. Burckhart JK, Wiebel FA, Hester S, Argon Y. The giant organelles in Beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes. J Exp Med 1993; 178: 1845-56.